Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01044680

Effects of NUTRIOSE®FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweight Adult Men

The Effects of NUTRIOSE®FB Dietary Fiber Supplementation on the Satiety, Body Fat Distribution, and Metabolic Syndrome Biomarkers of Overweight Adult Chinese Men 20-35 Years of Age.

Sponsor: Roquette Freres

Conditions Metabolic Syndrome X Overweight

Interventions NUTRIOSE Placebo

Updated 5 times since 2017 Last updated: Jan 7, 2010 Started: Oct 31, 2006 Primary completion: Feb 28, 2007 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01044680, this PHASE2/PHASE3 trial focuses on Metabolic Syndrome X and Overweight and remains completed. Sponsored by Roquette Freres, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Roquette Freres
Sprim Advanced Life Sciences

Data source: Roquette Freres

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China